Nutritional supplements: Amino acids and their derivatives

American Journal of Pharmaceutical Education

Volumn 66, Issue 2, 2002, Pages 157-164

  Joseph, Cecil K ^a,b  

^a LONG ISLAND UNIVERSITY   (United States)

^b Department of Biochemistry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 31144462558     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Field, C.J., Johnson, I. and Pratt, V.C., "Glutamine and arginine: Immunonutrients for improved health," Med. Sci. Sports Exerc., 32, S377-S388(2000).
2. Voet, D., Voet, J.G. and Pratt, C.W., Fundamentals of Biochemistry, John Wiley & Sons, Inc., New York NY (1999) p. 768.
3. Tangphao, O., Grossmann, M., Chalon, S., Hoffman, B.B. and Blaschke, T.F. "Pharmacokinetics of intravenous and oral L-arginine in normal volunteers," Br. J. Clin. Pharmacol., 47, 261-266(1999).
4. Boger, R.H. and Bode-Boger, S.M., "The clinical pharmacology of L-Arginine," Ann. Rev. Pharmacol. Toxicol., 41, 79-99(2001).
5. Lubec, B., Hayn, M., Kitzmuller E., Vierhapper, H. and Lubec, G., "L-arginine reduces lipid peroxidation in patients with diabetes mellitus," Free Rad. Biol. Med., 22, 355-357(1997).
6. Ceremuzynski, L., Chamiec, T. and Herbaczynska-Cedro, K., "Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris," Am. J. Cardiol., 80, 331-333(1997).
7. Carroll, K.K. and Kurowska, E.M., "Soy consumption and cholesterol reduction: Review of animal and human studies," J. Nutr., 125, 594S-597S(1995).
8. Potter, S.M., "Overview of the proposed mechanisms for the hypocholesterolemic effect of soy," J. Nutr., ibid., 125, 606S-611S(1995).
9. Sinclair, S., "Male infertility: Nutritional and environmental considerations," Altern. Med. Rev., 5, 28-38(2000).
10. Mindell, E., Earl Mindell's Supplement Bible, Simon & Schuster, New York NY (1998) p. 4.
11. Sandrini, G., Franchini, S., Lanfranchi, S. et al., "Effectiveness of ibuprofen-arginine in the treatment of acute migraine headaches," Int. J. Clin. Pharmacol. Res., 18, 145-150(1998).
12. Coomes, M.W., "Amino acid metabolism," in Textbook of Biochemistry with Clinical Correlations, 4th ed., (edit., Devlin, T.), John Wiley & Sons, Inc., New York NY (1997).
13. Odom, J.E., Kemp, G.J. and Radda, G.K., "The regulation of total creatine content in a myoblast cell line," Mol. Cell. Biochem., 158, 179-188(1996).
14. Guerrero-Ontiveros, M.L. and Wallimann, T., "Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: Down-regulation of the expression of creatine transporter isoforms in skeletal muscle," Mol. Cell. Biochem., ibid., 184, 427-437(1998).
15. Persky, A.M. and Brazeau, G.A., "Clinical pharmacology of the dietary supplement creatine monohydrate," Pharmacol. Rev., 53, 161-176(2001).
16. Feldman, E.B., "Creatine: A dietary supplement and ergogenic aid," Nutr. Rev., 57, 45-50 (1999).
17. Benzi, G. and Ceci, A., "Creatine as nutritional supplementation and medicinal product," J. Sports. Med. Phys. Fitness, 41, 1-10(2001).
18. Berneis, K., Ninnis, R., Haussinger, D. and Keller, U., "Effects of hyper- and hypoosmolality on whole body protein and glucose kinetics," Am. J. Physiol., 276, E188-E195(1999).
19. Felber, S., Skladal, D., Wyss, M., Kremser, C., Koller, A. and Sperl, W., "Oral creatine supplementation in Duchenne muscular dystrophy: A clinical and 31P magnetic resonance spectroscopy study," Neurol. Res., 22, 145-150(2000).
20. Gordon, A., Hultman, E., Kaiser, L., Kristjansson, S. Rolf, C.J., Nyquist, O. and Sylven, C., "Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance," Cardiovasc. Res., 30, 413-418 (1995).
21. Vandenberghe, K., Gillis, N., Van Leemputte, M., VanHecke, P., Vanstapel, F. and Hespel, P., "Caffeine counteracts the ergogenic action of muscle creatine loading," J. Appl. Physiol., 80, 452-457(1996).
22. Sachan, D.S., Rhew, T.H. and Ruark, R.A., "Ameloriating effects of carnitine on alcohol-induced fatty liver," Am. J. Clin. Nutr., 39, 738-744(1984).
23. Thal, L.J., Carta, A., Clarke, W.R., Ferris, S.H., Friedland, R.P., Petersen, R.C., Pettegrew, J.W., Pfeiffer, E., Raskind, M.A., Sano, M., Tuszynski, M.H. and Woolson, R.F., "A one-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease," Neurology 47, 705-711(1996).
24. "L-Carnitine," in PDR for Nutritional Supplements, 1st ed, (edits. Hendler, S.S. and Rorvik, D.), Medical Economics Co., Inc. Montvale NJ (2001) p. 10.
25. Brevetti, G., Diehm, C. and Lambert, D., "European multicenter study on propionyl-L-carnitine in intermittent claudication," J. Am. Coll. Cardiol., 34, 1618-1624(1999).
26. Kelly, G.S., "Insulin resistance: Lifestyle and nutritional interventions," Altern. Med. Rev., 5, 109-132(2000).
27. Brass, E.P., "Supplemental carnitine and exercise," Amer. J. Clin. Nutr., 72, 618S-623S(2000).
28. Werbach, M.R., "Nutritional strategies for treating chronic fatigue syndrome," Altern. Med. Rev., 5, 93-108(2000).
29. Cairus, P.A. and Stalker, D.J., "Carnitine supplementation of parenterally fed neonates," Cochrane Database Syst. Rev. 4, CD00950(2000).
30. Op. cit. (23), p. 258.
31. Op. cit. (23), p. 260.
32. Roederer, M., Ela, S.W., Staal, F.J., Herzenberg, L.A. and Herzenberg, L.A., "N-acetylcysteine: A new approach to anti-HIV therapy," AIDS Res. Hum. Retroviruses, 8, 209-217(1992).
33. Kelly, G., "Clinical applications of N-acetylcysteine," Altern. Med. Rev., 3, 114-127(1998).
34. Iversen, H.K., "N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial response," Clinical Pharmacol. Ther., 52, 125-133(1992)
35. Ju, C. and Ueterecht, J.P., "Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinonine intermediate," J. Pharmacol. Exp. Ther., 288, 51-56(1999).
36. Droge, W. and Breitkreutz, R., "Glutathione and immune function," Proc. Nutr. Soc., 59, 595-600(2000).
37. Sies, H., "Glutathione and its role in cellular functions," Free Rad. Biol. Med., 27, 916-921(1999).
38. Smyth, J.F., Bowman, A., Perren, T., Wilkinson, P., Prescott, R.J., Quinn, K.J. and Tedeschi, M. "Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: Results of a double-blind, randomized trial," Ann. Oncol., 8, 569-573 (1997).
39. Cascinu, S., Cordella, L., Del Ferro E., et al., "Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: A randomized double-blind placebo-controlled study," J. Clin. Oncol., 13, 26-32(1995).
40. Chavez, M. "SAMe: S-Adenosylmethionine," Am. J. Health-Syst. Pharm., 57, 119-123 (2000).
41. Stramentinoli, G., Gualano, M. and Galli-Kienle, M., "Intestinal absorption of S-adenosyl-L-methionine," J. Pharmacol. Exp. Ther., 209, 323-326(1979)
42. Herrmann, W., "The importance of hyperhomocysteinemia as a risk factor for diseases: An overview." Clin. Chem. Lab. Med., 39, 666-674(2001)
43. Op. cit. (9), p. 140.
44. Barcelo, V.A., Wiemeyer, J.C.M., Sagasta, C.L., Macias, M. and Barreira, J.C., "Effect of S-adenosylmethionine on experimental osteoarthritis in rabbits," Am. J. Med., 83(5A), 55-59(1987).
45. Fetrow, C.W. and Avila, J.R. "Efficacy of the dietary supplement S-adenosyl-L-methionine," Ann. Pharmacother., 35, 1414-1425(2001).
46. Chawla, R.K., Bonkskovsky, K.L. and Galambos, J.T., "Biochemistry and pharmacology of S-adenosylmethionine and rationale for its use in liver disease," Drugs, 40(Suppl 3), 98-110(1990).